Prognostic and predictive roles of KRAS mutation in colorectal cancer. - Wikidata - awgldk - TriplyDB

Prognostic and predictive roles of KRAS mutation in colorectal cancer.

Prognostic and predictive roles of KRAS mutation in colorectal cancer.

http://www.wikidata.org/entity/Q36396396

about

Mutational Analysis of Circulating Tumor Cells Using a Novel Microfluidic Collection Device and qPCR Assay Fibroblast growth factor receptor 1 as a putative therapy target in colorectal cancer.Molecular understanding of lung cancers-A review.The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients.Tumor location as a novel high risk parameter for stage II colorectal cancers.Resistance to Selumetinib (AZD6244) in colorectal cancer cell lines is mediated by p70S6K and RPS6 activation.Association between specific KRAS mutations and the clinicopathological characteristics of colorectal tumors.Biology of colorectal cancer.A specific KRAS codon 13 mutation is an independent predictor for colorectal cancer metachronous distant metastases Identification of O-Linked Glycoproteins Binding to the Lectin Helix pomatia Agglutinin as Markers of Metastatic Colorectal Cancer.Bioresponsive antisense DNA gold nanobeacons as a hybrid in vivo theranostics platform for the inhibition of cancer cells and metastasis.Association between proto-oncogene mutations and clinicopathologic characteristics and overall survival in colorectal cancer in East Azerbaijan, Iran.miR-155 is positively regulated by CBX7 in mouse embryonic fibroblasts and colon carcinomas, and targets the KRAS oncogene.Identification of Wee1 as a novel therapeutic target for mutant RAS-driven acute leukemia and other malignancies.Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma KRAS Mutation in Small Cell Lung Carcinoma and Extrapulmonary Small Cell Cancer.Sex differences in the prognostic significance of KRAS codons 12 and 13, and BRAF mutations in colorectal cancer: a cohort study.Important molecular genetic markers of colorectal cancer.Biomarker-driven EGFR therapy improves outcomes in patients with metastatic colorectal cancer.RAS mutation is a prognostic biomarker in colorectal cancer patients with metastasectomy.Current and future biomarkers in the treatment of colorectal cancer.Epidermal Growth Factor Receptor Signaling to the Mitogen Activated Protein Kinase Pathway Bypasses Ras in Pancreatic Cancer Cells.In vitro prediction of the efficacy of molecularly targeted cancer therapy by Raman spectral imaging.KRAS gene mutations in correlation with clinicopathological features of colorectal carcinomas in Indian patient cohort.In-Gene Quantification of O(6)-Methylguanine with Elongated Nucleoside Analogues on Gold Nanoprobes.Activating KRAS mutations are characteristic of oncocytic sinonasal papilloma and associated sinonasal squamous cell carcinoma.Gene Silencing Using Multifunctionalized Gold Nanoparticles for Cancer Therapy.The Yeast Saccharomyces cerevisiae as a Model for Understanding RAS Proteins and their Role in Human Tumorigenesis.PCR free multiple ligase reactions and probe cleavages for the SNP detection of KRAS mutation with attomole sensitivity.KRAS, BRAF oncogene mutations and tissue specific promoter hypermethylation of tumor suppressor SFRP2, DAPK1, MGMT, HIC1 and p16 genes in colorectal cancer patients.AZD-4547 exerts potent cytostatic and cytotoxic activities against fibroblast growth factor receptor (FGFR)-expressing colorectal cancer cells.LYTAK1, a novel TAK1 inhibitor, suppresses KRAS mutant colorectal cancer cell growth in vitro and in vivo.Viable pigs with a conditionally-activated oncogenic KRAS mutation.A phase IB trial of the oral MEK inhibitor trametinib (GSK1120212) in combination with everolimus in patients with advanced solid tumors.

P2860

Q24608051-1E7C0FEC-5CFF-4985-8575-0D0B44A6DA95 Q27852581-94F0339C-3DB1-4A83-A722-8144F2111C39 Q33628898-C5307AF9-9423-4FC1-AF80-03E3A1C7843F Q33768220-BB3D9E0C-4B05-43E4-9DF3-7C71E1B88269 Q33828917-819A5CC6-4768-484C-8CA4-9BBD33F08443 Q34417585-6A8C5B51-7178-41E7-B0AC-2C71230F4CD9 Q34607305-024F91D9-20F5-479E-AF45-214C2DF2F432 Q34669618-410CDDE6-2AED-4F11-8AFF-B0FF8222431D Q35402251-76B3D108-D0E3-431C-8824-D7D2AF13E14C Q35818634-55A2CDDC-7B24-4F01-BEC7-1AE5996E081D Q35865494-88D80362-A66A-4033-94C9-F134905C2314 Q36229011-A932ADEF-F599-4BED-B90A-A594ECBE44C1 Q36297213-E59C96C4-4151-4753-84D0-92DEE994B8A3 Q36341628-0679F70C-D90B-40B8-94D6-6C3DC6CDEDB0 Q37107712-89664382-9FAB-4567-9538-C57B6B76FEFA Q37211434-5C38692F-8A40-4C78-8F81-28AC30948411 Q37355802-11BF2D8A-1046-4826-921E-CB8E333892AB Q37619856-8E69DABC-2CE8-49C9-AD26-F00C4ABBBE5E Q38217738-4602E4C0-F1F5-43E4-98DF-1A07AD34CE97 Q38785379-12F1D99E-8505-472D-AF6B-39D12A8B9E8F Q38787244-558D07CC-9EF2-46A9-AA58-249676C0786B Q38844551-1BE604E4-0306-4626-9965-5970CF7AFBAB Q38853649-E6918E7E-6408-4EAF-AAB6-B2FE095747BF Q45764349-74485C6F-83F1-4C08-83D5-859758FAFB2A Q47101134-8E5C7336-16DC-406E-9959-3373B878AC43 Q48220009-C679ACF1-2DE4-4C29-9920-77BA144295C5 Q48848435-CB305FFB-4DF4-4B65-B59A-5437B24E8F23 Q49798156-7C60AAA5-7D85-46E1-95A7-5C741D83A8FB Q51107893-8F187435-66DD-4D92-A2FD-77C21DD99E33 Q51562493-DC18AEEE-1DC5-4374-BC70-A3C38F2E4FEA Q52966220-BD67C1C6-B3EC-4EB2-85D6-B988677AF21B Q52981342-5C09A53A-868A-4CF1-8A86-06A909267758 Q53223303-2C926A4D-1D74-441C-AE95-D60E941164CF Q53253771-3A19A8C9-AF7E-43A5-9515-0D96D06496EA

P2860

Prognostic and predictive roles of KRAS mutation in colorectal cancer.

http://www.wikidata.org/entity/Q36396396

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Prognostic and predictive roles of KRAS mutation in colorectal cancer.

@ast

Prognostic and predictive roles of KRAS mutation in colorectal cancer.

@en

type

label

Prognostic and predictive roles of KRAS mutation in colorectal cancer.

@ast

Prognostic and predictive roles of KRAS mutation in colorectal cancer.

@en

prefLabel

Prognostic and predictive roles of KRAS mutation in colorectal cancer.

@ast

Prognostic and predictive roles of KRAS mutation in colorectal cancer.

@en

P1433

Q36396396-0577BA25-66F6-4F7A-BB55-6781235824C4

P1476

Q36396396-2A5C54C1-D9CD-457B-BEFA-07F9951C3990

P2093

Q36396396-248CEF80-CE7F-47A1-8103-F37C8B08183B

Q36396396-6F3AA3DB-4826-42F8-B030-5D35664E8635

Q36396396-723E0D11-6C46-4255-94F3-EA207506055B

Q36396396-88607251-2C7A-488E-9B24-185CAF337913

Q36396396-BCA9C588-5FF6-4F7C-92EC-14CE96385153

Q36396396-D25C5A81-FA7B-481C-B4AA-0C07971A9678

Q36396396-D2A93A47-458D-4E65-85F3-541186260132

Q36396396-D97EDD11-74AC-4BFF-8CA8-C8D31FCA8834

P275

Q36396396-C8F2D401-068F-419C-9B9A-4797411E3347

P2860

Q36396396-01015BF2-D4DA-435E-ACA0-C6C9DDEB847F

Q36396396-0891A416-4A2C-4477-A45F-6B61C4006169

Q36396396-0C83074B-3BDB-41CF-BA3B-54C1C2743CA4

Q36396396-0D80F45E-859A-411D-B21D-19EBDCA1253A

Q36396396-0F65EE37-1EDC-48F3-9F98-2C95C19B1911

Q36396396-14854F74-B7B7-4503-A0E9-AD34DBB98B95

Q36396396-15A77CB7-120B-47A9-99BA-A2E2CB744DF0

Q36396396-17D775E6-D1D0-40AF-B138-B5A9C8518A7A

Q36396396-1B016921-2ADD-4070-9349-EFF9BC5B91CC

Q36396396-2192BE2B-CEA4-47C6-97B8-61CC9D3CED9B

P304

Q36396396-C6B6117F-0915-49AF-BE7E-AF14749F5991

P31

Q36396396-D6B95D85-2092-40D6-B1EF-FB6969A884F3

Q36396396-F8ADA8D7-95F6-45DF-AF40-C86CED703DB6

P356

Q36396396-B95F852F-2259-4429-8BFD-A61B8274DDD6

P407

Q36396396-E0B3ABD2-6642-4373-BB29-1D41C554F326

P433

Q36396396-7E9271A4-4A0A-49F9-B6E4-CD20EC3AF96A

P478

Q36396396-5EB0EECF-A12B-4BD5-8464-BE2E60BEC54B

P5008

Q36396396-4A0D70B7-9CB2-4B08-AE21-894EEEB0A37D

P577

Q36396396-7EB444A1-19C4-43A6-8299-86614A5AA648

P5875

Q36396396-CA8A1D82-67FC-42DD-A665-A69BF7202969

P698

Q36396396-C53C672A-7C8F-44F5-973A-FA37D978C30C

P921

Q36396396-052CCF10-515A-411E-BAB9-6B6C7FA6E97C

Q36396396-14A6AA9F-7A01-40D0-8C49-0E1B19149B9A

Q36396396-450E66D5-D506-42A8-842A-1FAC458C7529

Q36396396-5FF6C447-83C9-4E17-B5C9-AB32D979B957

Q36396396-BF290933-13C5-4EC4-B699-550CBE03668D

P932

Q36396396-40E14521-2C30-482E-B52B-2797D169CE90

P356

P1433

International Journal of Molecular Sciences

P1476

Prognostic and predictive roles of KRAS mutation in colorectal cancer.

@en

P2093

Amanda K Arrington

http://www.w3.org/2001/XMLSchema#string

Eileen L Heinrich

http://www.w3.org/2001/XMLSchema#string

Joseph Kim

http://www.w3.org/2001/XMLSchema#string

Julian Sanchez

http://www.w3.org/2001/XMLSchema#string

Julio Garcia-Aguilar

http://www.w3.org/2001/XMLSchema#string

Marjun Duldulao

http://www.w3.org/2001/XMLSchema#string

Supriya Patel

http://www.w3.org/2001/XMLSchema#string

Wendy Lee

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.

Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab.

RAS is regulated by the let-7 microRNA family

P304

12153-12168

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/IJMS131012153

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2012-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233829193

http://www.w3.org/2001/XMLSchema#string

P698

23202889

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

transport protein

colorectal neoplasm

P932

3497263

http://www.w3.org/2001/XMLSchema#string